Gujarat-based pharma companies are turning homewards, as their honeymoon period in the tax-free havens of hill states like Himachal Pradesh and Uttarakhand ends in March 2010.
Prime Minister Manmohan Singh underlined the importance of India and Russia in sustaining global economic recovery and said the two countries have decided to take bilateral trade to a much higher level of USD 20 billion by 2015.
The Indian Drug Manufacturers Association Gujarat State Board (IDMA -GSB) is organising India's largest pharma & healthcare exhibition 'Pharmac India 2009' in Ahmedabad from November 7 to 9. While Pharmexcil is the co-organiser of the event, it is supported by Federation of Pharma Entrepreneurs (FOPE), Sabarkantha District Drug Manufacturers Association, BDMA and Rajasthan Pharmaceutical Manufacturers Association.
With the goal of making treatment of tuberculosis more affordable to the common man, some major pharma companies in the country with the support of the government machinery, have commenced clinical trials of as many as seven TB drug candidates according to Union health ministry.
The industry has by and large hailed the Union budget for the financial year 2009-10 presented by finance minister Pranab Mukherjee.
The Department of Pharmaceuticals, in association with FICCI and other pharma organisations, is organising an international conference on pharmaceuticals in Mumbai on November 30, ahead of the proposed CPHI happening from next day, to showcase strength of Indian companies.
In its endeavour to help pharma players from other parts of the world to explore Japanese drug market, the second largest in the world, United Business Media, a leading organiser of trade shows and professional shows in Europe, US and Asia, would host its flagship event CPhI Japan at Tokyo Big Sight Exhibition Centre, Tokyo from April 21 to 23, 2009.
Drugmakers, such as Dr Reddy’s Laboratories, Wyeth, GlaxoSmithKline (GSK) Pharmaceuticals and Alkem Laboratories, may now have to face state officials for failing to pay up penalties for overpricing.
In a move to boost the bilateral trade relationship between Malaysia and India, Malaysian Biotechnology Corporation (BiotechCorp), the lead development agency for the biotechnology industry in Malaysia, kicked off their first business development engagement for 2009 in Hyderabad and Chennai with the Indian media members and industry participants. The latest updates on the Indian-Malaysian investment initiatives were shared to address the current challenging economic climate.
A mutation in one of the major genes involved in maintaining the structure of cardiac muscle and regulated cardiac condition in Indians may accelerate the number of cardiac patients in India, according to a study conducted by a team of scientists lead by the Hyderabad-based Centre for Cellular and Molecular Biology (CCMB).
The department of Ayush in association with Federation of Indian Chambers of Commerce and Industry (FICCI) is organising 'Arogya 2009 – Mumbai' for the first time in Mumbai from January 30 to February 2, 2009. The four-day event will be held at MMRDA Grounds, Bandra Kurla Complex, Bandra East.
According to a new study published in the early online edition of Proceedings of the National Academy of Sciences of the USA (PNAS), scientists from the Université de Montréal and the Maisonneuve-Rosemont Hospital Research Centre have identified a new biochemical pathway which controls such DNA repair.
Indian pharmaceutical machines are gaining more and more acceptance in international markets. Today, the companies are exploring advanced markets such as the USand Europe for their machinery…[English]-[French]-[Spanish]
The Indian Patent Office received 1,000 applications electronically – about 3 per cent of the country's total filing of patent applications – in less than a year of receipt of the first application filed electronically on 13 July 2007.
Watson Pharmaceuticals, Inc. a leading specialty pharmaceutical company, under a supply agreement with Solvay Pharmaceuticals, Inc., Watson has launched the authorized generic version of dronabinol in the 2.5, 5 and 10 mg once daily dosage strengths.
Cytokinetics Incorporated, has agreed to extend the research term under its strategic alliance with GlaxoSmithKline (GSK) to continue research activities focused towards the mitotic kinesin centromere-associated protein E (CENP-E).
May 8-9, 2008 – New Delhi- MACHINERY HEALTH MANAGEMENT:Federation of Indian Chambers of Commerce and Industry is organizing the second edition of "MACHINERY HEALTH MANAGEMENT" during May 8-9, 2008 at Federation House, New Delhi. The areas of discussion are :Importance of Machinery Health Management in Indian Industries; Emerging Trends in Machinery Maintenance ManagementReliability Centered Maintenance
ACG Worldwide, largest capsule manufacturer has strengthen its presence in Eupope by acquiring Lukaps of Croatia – the largest manufacturer of hard gelatine capsule in Europe. This takeover will increase their production capacity.
Indian pharmaceutical machines are gaining more and more acceptance in International market. The companies are exploring advanced markets like US and Europe for their machinery.
According to new report, published by the Freedonia Group, the world wide demand for pharmaceutical packaging is set to rise to 5.9 % annually to over $34 billion in 2011 and $45billion by 2016